A new therapy designed at Penn State has turned one of cancer's tactics against it. The team camouflaged a cancer-killing drug using cells from the tumor itself, allowing them to sneak medicine past the tumor’s defenses like a nanoscale Trojan horse and deliver a killing blow from the inside.
Continue Reading
The Office of Environmental Health Hazard Assessment is set to overturn a controversial court decision that proposed all coffee shops in California brand coffee with a cancer warning label. The regulation is a new chapter in the long-running battle over whether a cup of coffee is a cancer risk.
Continue Reading
Strong and light, spider silk is one of the most impressive materials in the natural world. Now, scientists in Germany and Switzerland have found a new use for spider silk – wrapping up cancer drugs to protect them until they can reach their tumorous targets.
Continue Reading
A breakthrough study from researchers at the University of Melbourne has uncovered a vital genetic mechanism that sheds light on how a vital cancer-suppressing gene prevents tumors from developing.
Continue Reading
Two new studies are raising concerns that the CRISPR-Cas9 gene editing system could trigger an increased cancer risk in cells. With human trials using the technique starting this year, the scientists behind these new studies urge researchers to be aware of this cancer-driving mechanism.
Continue Reading
Scientists at University of Texas Southwestern have found that artificially boosting a natural cellular recycling process extends health and life expectancy in mice, with interesting implications for humans.
Continue Reading
Gas embolotherapy involves creating tiny bubbles in tumor blood vessels, which block the blood supply and starve the cancer out. Now, researchers from China and France have found that the technique could also deal a second blow as a drug delivery system.
Continue Reading
A case study from an ongoing clinical trial has revealed an experimental immunotherapy treatment has cured a breast cancer patient. The patient, with advanced breast cancer, was given three months to live before enrolling into the trial. Within weeks her tumors had disappeared.
Continue Reading
A new study has reignited the long-standing controversy of the safety of triclosan, an antibacterial compound found in scores of household products. The research, at this stage only verified in mice, found the chemical increases inflammation in the colon and reduces the diversity of gut flora.
Continue Reading
Those diagnosed with glioblastoma don’t have many treatment options – and usually a median life expectancy of just over a year. Now, researchers at MIT have developed nanoparticles that could provide hope, crossing the blood-brain barrier and delivering two types of drugs to fight tumors.
Continue Reading
See the stories that matter in your inbox every morning